Answer
Yes, acute pancreatitis has been observed with linagliptin, a component of Glyxambi; Glyxambi should be discontinued if pancreatitis is suspected, not restarted if acute pancreatitis is confirmed, and used cautiously in patients with a history of pancreatitis.
Sources for this answer
- Glyxambi 10 mg/5 mg film-coated tablets and Glyxambi 25 mg/5 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked